We, at Aditum, are focused on creating innovative diagnostic and treatment solutions that are accurate, affordable and accessible. We are a small start-up with big impact goals. Our platform is built on cutting-edge Bio-IT tools and algorithms, that identify, interpret and correlate biological data to clinical outcomes, enabling novel diagnostic and drug discovery. The technology we develop is as relevant to the current COVID-19 crisis, as it will be in shaping the future. Our team's collective expertise, ranging from AI/ML data science, bioinformatics and molecular biology to marketing and management, gives us a unique competitive advantage in our journey from concept to customer.